Endo International Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 4.78, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2023. Average receivable collection period, for the Endo International Plc in Dec 31 2023 quarter, has decreased to 76 days, compared to 79 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 414 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 2384 to 2961.

What is Receivable Turnover Ratio?
What is Endo International Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ENDPQ Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	-21.67 %	-8.5 %	-8.87 %	-2.95 %	-16.56 %
Y / Y Revenue Change	-10.45 %	-16.62 %	-3.91 %	-21 %	-29.59 %
Receivable Turnover Ratio (TTM)	4.78	4.63	4.73	4.67	4.93
ENDPQ's Total Ranking	# 2961	# 2384	# 2474	# 2957	# 1791
Accounts Receivable average collection period days	76	79	77	78	74
Seq. Receivable Change	-0.15 %	-13.49 %	-2.5 %	-7.01 %	16.66 %
Seq. Revenue Change	10.2 %	-17.41 %	6.13 %	-7.29 %	2.61 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 135
Healthcare Sector	# 415
Overall Market	# 2961

Receivable Turnover Ratio Statistics
High	Average	Low
6.18	4.72	1.98
(Jun 30 2020)		(Sep. 30, 2015)

ENDPQ Company Profile • Back to ENDPQ Efficiency Comparisons • Compare ENDPQ Receivables Turnover Ratio to its Competitors

Financial Statements
Endo International Plc's Accounts Receivable	$ 387 Millions	Visit ENDPQ's Balance sheet
Endo International Plc's Sales TTM	$ 2,012 Millions	Visit ENDPQ's Income Statement
Sources of ENDPQ's Revenues		Visit ENDPQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ENDPQ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ENDPQ's Growth Rates	ENDPQ's Roa	ENDPQ's Inventory Turnover Ratio	ENDPQ's Dividend Comparisons
ENDPQ's Profitability Ratios	ENDPQ's Roi	ENDPQ's Asset Turnover Ratio	ENDPQ's Dividend Growth
ENDPQ's Valuation Ratios	ENDPQ's Roe	ENDPQ's Financial Strength Ratios	ENDPQ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Centogene N v	14.16	$ 54.319 Millions	$ 3.836 Millions
Newgenivf Group Limited	14.12	$ 5.136 Millions	$ 0.364 Millions
Patterson Companies Inc	14.11	$ 6,565.239 Millions	$ 465.318 Millions
Utah Medical Products Inc	14.01	$ 50.097 Millions	$ 3.575 Millions
Corcept Therapeutics Inc	13.70	$ 482.375 Millions	$ 35.215 Millions
Theralink Technologies Inc	13.67	$ 0.511 Millions	$ 0.037 Millions
Precipio inc	13.43	$ 15.197 Millions	$ 1.132 Millions
Protalix Biotherapeutics inc	13.39	$ 65.494 Millions	$ 4.890 Millions
Lifeloc Technologies Inc	13.20	$ 9.330 Millions	$ 0.707 Millions
Exact Sciences Corporation	13.11	$ 2,507.149 Millions	$ 191.178 Millions
Traws Pharma inc	12.91	$ 0.226 Millions	$ 0.018 Millions
Fate Therapeutics Inc	12.90	$ 63.533 Millions	$ 4.924 Millions
Ideaya Biosciences Inc	12.73	$ 23.385 Millions	$ 1.837 Millions
Amylyx Pharmaceuticals Inc	12.65	$ 380.786 Millions	$ 30.108 Millions
Mdxhealth Sa	12.65	$ 70.193 Millions	$ 5.551 Millions
Valion Bio Inc	12.54	$ 1.176 Millions	$ 0.094 Millions
Teladoc Health Inc	12.18	$ 2,602.415 Millions	$ 213.613 Millions
International Stem Cell Corporation	12.13	$ 7.789 Millions	$ 0.642 Millions
Caribou Biosciences Inc	12.12	$ 34.477 Millions	$ 2.844 Millions
Zomedica Corp	12.01	$ 24.318 Millions	$ 2.025 Millions
Avita Medical Inc	11.98	$ 50.143 Millions	$ 4.185 Millions
Talis Biomedical Corporation	11.96	$ 2.134 Millions	$ 0.179 Millions
Nutriband Inc	11.81	$ 2.085 Millions	$ 0.177 Millions
Siga Technologies Inc	11.78	$ 139.917 Millions	$ 11.881 Millions
Thermogenesis Holdings Inc	11.73	$ 8.931 Millions	$ 0.762 Millions
Singular Genomics Systems Inc	11.53	$ 2.911 Millions	$ 0.253 Millions
Sunshine Biopharma Inc	11.49	$ 24.093 Millions	$ 2.097 Millions
Integrated Biopharma Inc	11.42	$ 48.833 Millions	$ 4.275 Millions
Surmodics Inc	11.40	$ 138.203 Millions	$ 12.123 Millions
Petvivo Holdings Inc	11.12	$ 1.046 Millions	$ 0.094 Millions

Date modified: 2026-06-22T16:30:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.